Could someone clarify; in ‘New Pathways’ it states in an Italian study has found 76% of MS patients compared to 16% of controls had CCSVI published in BMC Neurology February 2013.
Published date: 15 Mar 2013 at 10:20AM
The first of seven CCSVI studies funded by the National MS Society and the MS Society of Canada has published its results, which showed no increase in prevalence of CCSVI in people with MS.
Researchers from the University of Texas Health Science Centre at Houston used sonography techniques to measure blood outflow from the brain to establish whether any of the participants in the study fulfilled the criteria for CCSVI.
276 people were assessed for CCSVI (206 with MS and 70 without). The researchers found that CCSVI was present in 3.88% of people with MS and 7.14% of people without MS. These results showed no significant differences in blood flow rates between people with MS and people without.
The results were published in the journal Annals of Neurology.
Questions arise from these reports but mainly how can two completely different trials have findings so different? I personally have no interest in CCSVI (Snake Venom is my forte) but it does seem to ridicule double blind studies.